Brief: Cadrenal Therapeutics To Conduct Partnering And Investor Meetings
17/12/2025 14:52
Dec 17 (Reuters) - Cadrenal Therapeutics Inc CVKD.O: CADRENAL THERAPEUTICS TO CONDUCT PARTNERING AND INVESTOR MEETINGS DURING THE J.P. MORGAN 44TH ANNUAL HEALTHCARE CONFERENCE IN SAN FRANCISCO ON JANUARY 12-15, 2026 Source text: ID:nGNX9Z2Jh2 Further company coverage: CVKD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cadrenal Therapeutics
See all newsCadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Cadrenal Therapeutics Q2 net loss narrows as operating expenses fall
Cadrenal Therapeutics Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology